BPC-157 vs Ipamorelin
Related research areas, distinct mechanisms. Live $/mg pricing across every tracked vendor.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
Both are commonly stacked in recovery-focused research protocols. They share an interest in supporting tissue turnover and post-injury recovery, which is why they're often discussed together.
BPC-157 acts directly on tissue-repair pathways (angiogenesis, growth-factor signaling). Ipamorelin is a GH secretagogue — it works upstream by pulsing endogenous growth hormone. The mechanisms are unrelated; they're complements, not alternatives.
BPC-157
Tissue-repair research peptide
Ipamorelin
Selective GH secretagogue
About BPC-157
BPC-157 is a synthetic peptide derived from a protective protein found in gastric juice. Widely studied in preclinical models for tendon, ligament, and gastrointestinal tissue recovery.
About Ipamorelin
A pentapeptide ghrelin-receptor agonist that selectively stimulates GH release without significant cortisol or prolactin increase.